ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer
Linhua Yang, Hui Wang, Miaomiao Guo, Min He, Wei Zhang, Ming Zhan, Yingbin Liu
Topics & Concepts
GemcitabineGallbladder cancerMedicineCyclin-dependent kinase 1Resistance (ecology)OncologyInternal medicineCancer researchCancerBiologyCell cycleEcologyCholangiocarcinoma and Gallbladder Cancer StudiesPancreatic and Hepatic Oncology ResearchLung Cancer Treatments and Mutations